These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37592417)

  • 1. Pharmacist Interventions for Adverse Drug Reactions in Palliative Care: A Multicentre Pilot Study.
    Kose E; Nakagawa S; Niki K; Hashizume J; Kawazoe T; Suzuki N; Uchida M; Takase H
    Pharmazie; 2023 Aug; 78(8):141-149. PubMed ID: 37592417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Economic Effect of Pharmaceutical Interventions by Board-Certified Pharmacists in Palliative Pharmacy for Patients with Cancer Using Medical Narcotics in Japan: A Multicenter, Retrospective Study.
    Kawashiri T; Sugawara H; Makihara K; Ohno R; Miyamoto Y; Hidaka N; Uchida M; Takase H
    J Nippon Med Sch; 2024; 91(1):59-65. PubMed ID: 38462441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical study for seminar program certified by Japanese Society of Hospital Pharmacists for Clinical Psychiatric Pharmacists organized by Chiba Society of Hospital Pharmacists, and investigation of participants' background and issues for taking board certified psychiatric pharmacy specialists and board certified pharmacists in psychiatric pharmacy certifications using questionnaires].
    Tsukiji M; Furuyama H; Hasegawa T; Ishida K; Matsuda K; Fukuda K; Shimizu H
    Yakugaku Zasshi; 2010 Sep; 130(9):1197-205. PubMed ID: 20823677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan.
    Uchida M; Suzuki S; Sugawara H; Suga Y; Kokubun H; Uesawa Y; Nakagawa T; Takase H
    J Pharm Health Care Sci; 2019; 5():14. PubMed ID: 31308953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese Nationwide Comparative Survey of Medication Guidance Provided by Certified and Uncertified Palliative Care Pharmacists.
    Tanaka R; Satoh Y; Suga Y; Nakagawa J; Miyazaki M; Hagiwara R; Uchida M; Takase H
    J Nippon Med Sch; 2023; 90(6):449-459. PubMed ID: 38246616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Related Problems on a Palliative Care Unit.
    Rémi C; Bauer D; Krumm L; Bausewein C
    J Pain Palliat Care Pharmacother; 2021 Dec; 35(4):264-272. PubMed ID: 34460343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncology pharmacist as part of the palliative treatment team.
    Crul M; Oosterhof P
    Int J Pharm Pract; 2020 Feb; 28(1):92-96. PubMed ID: 31576620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
    Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
    J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
    Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
    J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care.
    Needham DS; Wong IC; Campion PD;
    Palliat Med; 2002 May; 16(3):219-25. PubMed ID: 12046998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of emergency department pharmacists on drug overuse and drug underuse in patients with an ADE-related hospitalisation: a controlled intervention study.
    Rahman RN; Nikolik B; de Ridder MAJ; Hoek AE; Janssen MJA; Schuit SCE; Karapinar-Çarkit F; van den Bemt PMLA
    BMC Health Serv Res; 2022 Nov; 22(1):1363. PubMed ID: 36397102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a residential care pharmacist on medication administration practices in aged care: A controlled trial.
    McDerby N; Kosari S; Bail K; Shield A; Peterson G; Naunton M
    J Clin Pharm Ther; 2019 Aug; 44(4):595-602. PubMed ID: 30793340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knowledge and attitude about Pharmacovigilance practices of pharmacy professionals of community pharmacy and hospital pharmacy in Spain.].
    Lozano Fernández R; Vera Sánchez E; Lozano Estevan MDC; Madurga Sanz M; Serna Núñez A
    Rev Esp Salud Publica; 2020 Jul; 94():. PubMed ID: 32669534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].
    Claeys C; Dufrasne M; De Vriese C; Nève J; Tulkens PM; Spinewine A
    J Pharm Belg; 2015 Mar; (1):42-54. PubMed ID: 26571796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist services for non-hospitalised patients.
    de Barra M; Scott CL; Scott NW; Johnston M; de Bruin M; Nkansah N; Bond CM; Matheson CI; Rackow P; Williams AJ; Watson MC
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD013102. PubMed ID: 30178872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nationwide Survey of Community Pharmacist Contributions to Polypharmacy in Opioid-Using and Non-using Cancer Patients in Japan.
    Suzuki S; Uchida M; Suga Y; Sugawara H; Kokubun H; Uesawa Y; Nakagawa T; Takase H
    Biol Pharm Bull; 2019 Jul; 42(7):1164-1171. PubMed ID: 30996146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing pharmacists' detection of prescribing errors: Comparison of on-ward and central pharmacy services.
    Lagreula J; Maes F; Wouters D; Quennery S; Dalleur O
    J Clin Pharm Ther; 2021 Jun; 46(3):738-743. PubMed ID: 33768608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.